SA
FBRX logo
Forte Biosciences, Inc.(FBRX)
Closing price · checked 4:30 PM ETAbout this dataData status
$76.99▲0.00 (0.00%)
Extended:$77.00+0.01 (+0.01%)· 4:30 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Forte Biosciences, Inc. (FBRX)

Operating Cash Flow (Statement)

-$71.98M

TTM · Period ending: · USD

FBRX logo

FBRX Operating Cash Flow (Statement)

Latest reported-$71.98M
FBRX Cash from Operations (-$21.04M → -$71.98M)
High-resolution chart · PNG

What is operating cash flow (statement)?

Net cash provided by operating activities.

FBRX operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Forte Biosciences, Inc. Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)Change
-50,882,000—
-30,745,000—
-28,706,000—
-8,185,000—
-16,677,000—
-18,423,000—
-2,771,000—
-34,469,000—
-31,133,000—
-29,539,000—
-21,042,000—

Frequently asked questions: FBRX operating cash flow (statement)

What is Forte Biosciences, Inc. (FBRX)'s current operating cash flow (statement)?

Forte Biosciences, Inc. (FBRX)'s latest reported operating cash flow (statement) (TTM) is -$71.98M as of Jun 30, 2026. Net cash provided by operating activities.

How much historical operating cash flow (statement) data is available for FBRX?

Stock Alarm Pro provides 11 dated annual fiscal periods observations for Forte Biosciences, Inc. (FBRX)'s operating cash flow (statement), allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare FBRX's operating cash flow (statement) to peers or set an alert?

You can open FBRX's operating cash flow (statement) in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on FBRX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.